Hormesis: Its impact on medicine and health

Human and Experimental Toxicology

Volumn 32, Issue 2, 2013, Pages 120-152

  Calabrese, E J ^a   Iavicoli, I ^b   Calabrese, V ^c  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

Author keywords

adaptive response; biphasic; Hormesis; hormetic; J shaped; personalized medicine; U shaped

Indexed keywords

ACETYLCHOLINE; ADENOSINE RECEPTOR; ADRENERGIC RECEPTOR; ANTIBIOTIC AGENT; BRADYKININ RECEPTOR; CHOLECYSTOKININ RECEPTOR; CORTICOSTERONE; DISINFECTANT AGENT; DOPAMINE RECEPTOR; ENDOTHELIN RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; LUTEINIZING HORMONE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROPEPTIDE; NEUROPEPTIDE RECEPTOR; NEUROTENSIN RECEPTOR; NITRIC OXIDE; OPIATE RECEPTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROLACTIN RECEPTOR; PROSTAGLANDIN RECEPTOR; SEROTONIN RECEPTOR; SOMATOMEDIN RECEPTOR; SOMATOSTATIN RECEPTOR; SPERMINE; SUBSTANCE P RECEPTOR; TESTOSTERONE; UNINDEXED DRUG;

ANTIBODY PRODUCTION; ARTICLE; CARDIOVASCULAR RISK; CELL PROLIFERATION; CHEMICAL INTERACTION; CLINICAL PHARMACOLOGY; DOSE RESPONSE; DRUG INDUSTRY; DRUG RESPONSE; FOOD AND DRUG ADMINISTRATION; HEART INFARCTION; HEART INJURY; HOMEOPATHY; HORMESIS; HUMAN; HYPERTENSION; HYPOXIA; INSULIN RESISTANCE; MEDICAL RESEARCH; MOLECULAR BIOLOGY; NON PROFIT ORGANIZATION; NONHUMAN; PERSONALIZED MEDICINE; PHYSICIAN; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUBLIC HEALTH; PUBLIC HEALTH SERVICE; RISK ASSESSMENT; SCIENTIFIC LITERATURE; SCIENTIST; TENDON INJURY; TENDON RUPTURE; TRADITIONAL MEDICINE; TREATMENT DURATION; TREATMENT RESPONSE; TUMOR CELL; WOUND HEALING; YEAST;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DISCOVERY; HEALTH; HORMESIS; HUMANS; MEDICINE;

EID: 84872295104     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327112455069     Document Type: Article

References (235)

1. Calabrese EJ Pharmacology: principles and practices. Bachmann K Hacker M and Messer W, ed. London: Elsevier Publishers ; 2009: 75-102.
2. Eaton DL, Klaassen CD Cassarett and Doull's essentials of toxicology. Klaasen CD and Watkins III JB, ed. New York, NY: McGraw-Hill ; 2003: 6-20.
3. Beck B, Calabrese EJ, Slayton TM, Rudel T Principles and methods of toxicology. 5 th ed. Boca Raton, FL: CRC Press, 2007, pp. 45-102. Hayes AW, ed. Boca Raton, FL: CRC Press ; 2007: 45-102.
4. Le Bourg E, Rattan SIS Mild stress and healthy aging: applying hormesis in aging research and interventions. New York, NY: Springer ; 2008: 1-4.
5. Mattson MP, Calabrese EJ Hormesis: a revolution in biology, toxicology and medicine. New York, NY: Springer ; 2010: 213.
6. Sanders CL Radiation hormesis and the linear-no-threshold assumption. New York, NY: Springer ; 2010: 217.
7. Elliott K Is a little pollution good for you? Incorporating societal values in environmental research. New York, NY: Oxford University Press ; 2011: 264.
8. Stebbing T A cybernetic view of biological growth: the Maia hypothesis. Boston, MA: Cambridge University Press ; 2011: 456.
9. Kaiser J. Sipping from a poisoned chalice. Science. 2003 ; 302: 376-379
10. Calabrese EJ, Baldwin LA. Toxicology rethinks its central belief. Nature. 2003 ; 421: 691-692
11. Calabrese EJ. Hormesis: why it is important to toxicology and toxicologists. Environ Toxicol Chem. 2008 ; 27: 1451-1474
12. Calabrese EJ, Iavicoli I, Calabrese V. Hormesis: why it is important to biogerontologists. Biogerontology. 2012 ; 13: 215-235
13. Calabrese EJ, Baldwin LA. Defining hormesis. Hum Exp Toxiocol. 2002 ; 21: 91-97
14. Calabrese EJ, Baldwin LA. Hormesis and high risk groups. Regul Toxicol Pharmacol. 2002 ; 35: 414-428
15. Calabrese EJ. Toxicology rewrites its history and rethinks its future: giving equal focus to both harmful and beneficial effects. Environ Toxicol Chem. 2011 ; 30: 1658-1673
16. Calabrese EJ. Evidence that hormesis represents an " overcompensation" response to a disruption in homeostasis. Ecotoxicol Environ Saf. 1999 ; 42: 135-137
17. Branham SE. The effects of certain chemical compounds upon the course of gas production by baker's yeast. J Bacteriol. 1929 ; 18: 247-264
18. Schulz H. Zur Lehre von der Arzneiwirdung. Virchows Arch Pathol Anat Physiol Klin Med. 1887 ; 108: 423-445
19. Schulz H. Uber Hefegifte. Pflugers Archiv fur die gesamte Physiologie des Menschen und der Tiere. 1888 ; 42: 517-541
20. Stebbing ARD. Hormesis: the stimulation of growth by low-levels of inhibitors. Sci Total Environ. 1982 ; 22: 213-234
21. Stebbing ARD. A theory for growth hormesis. Mutat Res. 1998 ; 403: 249-258
22. Calabrese EJ. Overcompensation stimulation: a mechanism for hormetic effects. Crit Rev Toxicol. 2001 ; 31: 425-470
23. Calabrese EJ, Blain R. The occurrence of hormetic dose responses in the toxicological literature, the hormesis database: an overview. Toxicol Appl Pharmacol. 2005 ; 202: 289-301
24. Southam CM, Erhlich J. Effects of extracts of western red-cedar heartwood on certain wood-decaying fungi in culture. Phytopathol. 1943 ; 33: 517-524
25. Calabrese EJ, Baldwin LA. Chemical hormesis: its historical foundations as a biological hypothesis. Hum Exp Toxicol. 2000 ; 19: 2-31
26. Crump T.. Contemporary medicine as presented by its practitioners themselves, Leipzig, 1923:217-250, Hugo Schulz. NIH Library Translation (NIH-98-134). Nonlinearity Biol Toxicol Med. 2003 ; 1: 295-318
27. Hueppe F. Principles of bacteriology. Jordan EO, ed. Chicago, IL: The Open Court Publishing Company ;
28. Broadhurst PL. Emotionality and the Yerkes-Dodson law. J Exp Psychol. 1957 ; 54: 345-352
29. Calabrese EJ.. Stress biology and hormesis: The Yerkes-Dodson law in psychology: a special case of the hormesis dose response. Crit Rev Toxicol. 2008 ; 38: 453-462
30. Calabrese EJ. Converging concepts: adaptive response, preconditioning, and the Yerkes-Dodson law are manifestations of hormesis. Aging Res Rev. 2007 ; 7: 8-20
31. Calabrese EJ, Bachmann KA, Bailer AJ, et al. Biological stress response terminology: integrating the concepts of adaptive response and preconditioning stress within a hormetic dose response framework. Toxicol Appl Pharmacol. 2007 ; 222: 122-128
32. Calabrese EJ, Baldwin LA. The marginalization of hormesis. Hum Exp Toxicol. 2000 ; 19: 32-40
33. Calabrese EJ, Baldwin LA. Radiation hormesis: its historical foundations as a biological hypothesis. Hum Exp Toxicol. 2000 ; 19: 41-75
34. Calabrese EJ, Baldwin LA. Radiation hormesis: the demise of a legitimate hypothesis. Hum Exp Toxicol. 2000 ; 19: 76-84
35. Calabrese EJ, Baldwin LA. Tales of two similar hypotheses: the rise and fall of chemical and radiation hormesis. Hum Exp Toxicol. 2000 ; 19: 85-97
36. Calabrese EJ. Hormesis: from marginalization to mainstream. A case for hormesis as the default dose response model in risk assessment. Toxicol Appl Pharmacol. 2004 ; 197: 125-136
37. Calabrese EJ. Factors affecting the historical rejection of hormesis as a fundamental dose response model in toxicology and the broader biomedical sciences. Toxicol Appl Pharmacol. 2005 ; 206: 365-366
38. Calabrese EJ. Toxicological awakenings: the rebirth of hormesis as a central pillar of toxicology. Toxicol Appl Pharmacol. 2005 ; 204: 1-8
39. Calabrese EJ. Getting the dose-response wrong: why hormesis became marginalized and the threshold model accepted. Arch Toxicol. 2009 ; 83: 227-247
40. Calabrese EJ. Historical blunders: how toxicology got the dose response relationship half right. Cell Mol Biol. 2005 ; 51: 643-654
41. Szabadi E. A model of two functionally antagonistic receptor populations activated by the same agonist. J Theor Biol. 1977 ; 69: 101-112
42. Jarv J, Toomela T, Karelson E. Dual effect of carbachol on muscarinic receptor. Biochem Mol Biol. 1993 ; 30: 649-654
43. Jarv J. An alternative model for model-shaped concentration response curve. Trends Pharmacol Sci. 1994 ; 15: 321
44. Rovati GE, Nicosia S. Lower efficacy: interaction with an inhibitory receptor or partial agonism?. Trends Pharmacol Sci. 1994 ; 15: 140-144
45. Accomazzo MR, Cattaneo S, Nicosia S, Rovati GE. Bell-shaped curves for prostaglandin-induced modulation of adenylate cyclase: two mutually opposing effects. Eur J Pharmacol. 2002 ; 454: 107-114
46. Duggar B Plant physiology, with special reference to plant production. New York, NY: Macmillan ; 1911: 516.
47. Brenchley WE Inorganic plant poisons and stimulants. London: Cambridge University Press ; 1914 :
48. Salle AJ Fundamental principles of bacteriology. New York, NY: Mc-Graw-Hill ; 1939 :
49. Clifton CE Introduction to bacterial physiology. New York, NY: Mc-Graw-Hill ; 1957 :
50. Lamanna C, Mallette MF Basic bacteriology its biological and chemical background. MD: Williams & Wilkins ; 1965 :
51. Clark AJ Mode of action of drugs on cells. London: Arnold ; 1933 :
52. Clark AJ Handbook of experimental pharmacology. Berlin, Germany: Verlig Von Julius Springer ; 1937 :
53. Moore PR, Evenson A, Luckey TD, McCoy E, Elvehjem CA, Hart EB. Use of sulfasuxidine, streptothricin and streptomycin in nutritional studies with the chick. J Biol Chem. 1946 ; 165: 437-441
54. Luckey TD. Antibiotic growth stimulation. Br Med J. 1963 ; 534: 1284-1285
55. Luckey TD Hormesis with ionizing radiation. FL: CRC Press ; 1980 :
56. Calabrese EJ, Staudenmayer JW, Stanek EJ. Drug development and hormesis: changing conceptual understanding of the dose response creates new challenges and opportunities for more effective drugs. Curr Opin Drug Discov Dev. 2006 ; 9: 117-123
57. Calabrese EJ, Staudenmayer JW, Stanek EJ, Hoffmann GR. Hormesis outperforms threshold model in NCI antitumor drug screening data. Toxicol Sci. 2006 ; 94: 368-378
58. Calabrese EJ, Stanek EJ, Nascarella M, Hoffmann G. Hormesis predicts low-dose responses better than threshold models. Int J Toxicol. 2008 ; 27: 369-378
59. Calabrese EJ, Baldwin LA.. Hormesis: U-shaped dose responses and their centrality in toxicology. Trend Pharmacol. 2001 ; 22 (6). 285-291
60. Calabrese EJ, Baldwin LA. Adenosine: biphasic dose responses. Crit Rev Toxicol. 2001 ; 31: 539-552
61. Merkel LA, Lappe RW, Rivera LM, Cox BF, Perrone MH. Demonstration of vasorelaxant activity with an A1-selective adenosine agonist in porcine coronary artery: involvement of potassium channels. J Pharmacol Exp Therapeut. 1992 ; 260: 437-443
62. Calabrese EJ, Baldwin LA.. Adrenergic receptors: biphasic dose response. Crit Rev Toxicol. 2001 ; 31: 523-538
63. Toda N, Okamura T, Miyazaki M. Age-dependent changes in the response of isolated beagle coronary arteries transmural electrical stimulation and catecholamines. J Pharmacol Exp Therapeut. 1986 ; 238: 319-326
64. Calabrese EJ, Baldwin LA. Peptides and hormesis. Crit Rev Toxicol. 2003 ; 33 ((3-4)). 355-405
65. Bateson EAJ, Schulz R, Olley PM. Response of fetal rabbit ductus arteriosus to bradykinin: role of nitric oxide, prostaglandins, and bradykinin receptors. Pediatr Res. 1999 ; 45: 568-574
66. Korc M, Bailey AC, Williams JA. Regulation of protein synthesis in normal and diabetic rat pancreas by cholecystokinin. Am J Physiol. 1981 ; 241: G116 - G121
67. Calabrese EJ. Hormesis and medicine. Br J Clin Pharmacol. 2008 ; 66: 594-617
68. Abraham I, Harkany T, Horvath KM, et al. Chronic corticosterone administration dose-dependently modulates Aβ(1-42)- and NMDA-induced neurodegeneration in rat magnocellular nucleus basalis. J Neuroendocrinol. 2000 ; 12: 486-494
69. Calabrese EJ, Baldwin LA. Dopamine: biphasic dose response. Crit Rev Toxicol. 2001 ; 31: 563-584
70. Saller CF, Salama AI. D-1 and D-2 dopamine receptor blockade: interactive effects in vitro and in vivo. J Pharmacol Exp Therapeut. 1986 ; 236: 714-720
71. Granstrom B, Adner M, Uddman R, Edvinsson L, Cardell LO. Characterization of endothelin induced relaxation in guinea-pig airways: evidence for dilatory ETA- and ETB-receptors. Pulm Pharmacol Therapeut. 1997 ; 10: 293-298
72. Calabrese EJ. Cancer biology and hormesis: human tumor cell lines commonly display hormetic (biphasic) dose responses. Crit Rev Toxicol. 2005 ; 35: 463-582
73. Tsutsumi K, Kitagawa N, Niwa M, et al. Biphasic effects of suramin on 125I-epidermal growth factor binding to human meningiomas. Cell Mol Neurobiol. 1993 ; 13: 665-675
74. Calabrese EJ, Baldwin LA. Estrogen and related compounds: biphasic dose responses. Crit Rev Toxicol. 2001 ; 31: 503-516
75. Banerjee SK, Campbell DR, Weston AP, Banerjee DK. Biphasic estrogen response on bovine adrenal medulla capillary endothelial cell adhesion, proliferation and tube formation. Mol Cell Biochem. 1997 ; 177: 97-105
76. Calabrese EJ, Baldwin LA.. 5-Hydroxytryptamine (Serotonin): biphasic dose responses. Crit Rev Toxicol. 2001 ; 31: 553-562
77. Venugopalan CS, Moore RM, Holmes EP, Sedrish SA, Koch CE. Biphasic responses of equine colonic vessel rings to vascoactive inflammatory mediators. J Auton Pharmacol. 1998 ; 18: 231-237
78. Calabrese EJ, Baldwin LA. Opiates: biphasic dose responses. Crit Rev Toxicol. 2001 ; 31: 585-604
79. Cemerikic B, Cheng J, Agbas A, Ahmed MS. Opioids regulate the release of human chorionic gonadotropin hormone from trophoblast tissue. Life Sci. 1991 ; 49: 813-824
80. Lara JI, Lorenzo MJ, Cacicedo L, Tolon RM, Balsa JA. Induction of vasoactive intestinal peptide gene expression and prolactin secretion by insulin-like growth factor I in rat pituitary cells: evidence for an autoparacrine regulatory system. Endocrinol. 1994 ; 135: 2526-2532
81. Calabrese EJ. Pharmacological enhancement of neuronal survival. Crit Rev Toxicol. 2008 ; 38: 349-390
82. Khan S, Whelpton R, Michael-Titus AT. Substance P modulation of striatal dopamine outflow is determined by M1 and M2 muscarinic receptors in male Wistar rats. Neurosci Lett. 2000 ; 293: 179-182
83. Kastin AJ, Pan W. Peptides and hormesis. Crit Rev Toxicol. 2008 ; 38: 629-631
84. Urban MO, Coutinho SV, Gebhart GF. Biphasic modulation of visceral nociception by neurotensin in rat rostral ventromedial medulla. J Pharmacol Exp Therapeut. 1999 ; 290: 207-213
85. Calabrese EJ, Baldwin LA. Nitric oxide: biphasic dose response. Crit Rev Toxicol. 2001 ; 31: 489-502
86. Chae HJ, Park RK, Kang JS, et al. Effect of stem cell factor, interleukin-6, nitric oxide and transforming growth factor-β on the osteoclast differentiation induced by 1α,25-(OH)2D3 in primary murine bone marrow cultures. Pharmacol Toxicol. 1998 ; 82: 223-229
87. Brenneman DE, Forsythe ID, Nicol T, Nelson PG.. N-Methyl-d-aspartate receptors influence neuronal survival in developing spinal cord cultures. Dev Brain Res. 1990 ; 51: 63-68
88. Simpkins CO, Dickey CA, Fink MP. Human neutrophil migration is enhanced by beta-endorphin. Life Sci. 1984 ; 34: 2251-2255
89. Nemecek G, St.Denny I, Van Valen RG, McCarthy LA.. Terbinafine inhibits the mitogenic response to platelet-derived growth factor in vitro and neointimal proliferation in vivo. J Pharmacol Exp Therapeut. 1989 ; 248: 1167-1174
90. Calabrese EJ, Baldwin LA. Androgens: biphasic dose response. Crit Rev Toxicol. 2001 ; 31: 517-522
91. Welsh Jr, Kasson BG, Hsueh AJW. Direct biphasic modulation of gonadotropin-stimulated testicular androgen biosynthesis by prolactin. Biol Reprod. 1986 ; 24: 796-804
92. Calabrese EJ, Baldwin LA. Prostaglandins: biphasic dose response. Crit Rev Toxicol. 2001 ; 31: 475-488
93. Raisz LG, Simmons HA, Fall PM. Biphasic effects of nonsteroidal anti-inflammatory drugs on prostaglandin production by cultured rat calvariae. Prostaglandins. 1989 ; 37: 559-565
94. Ramirez JL, Castano JP, Gracia-Navarro F. Somatostatin at low doses stimulates growth hormone release from intact cultures of porcine pituitary cells. Horm Metab Res. 1998 ; 30: 175-177
95. Abe K, Chida N, Nishiyama N, Saito H. Spermine promotes the survival of primary cultured brain neurons. Brain Res. 1993 ; 605: 322-326
96. He X-Q, Chen R, Yang P, Li A-P, Zhou J-W, Liu Q-Z. Biphasic effect of arsenite on cell proliferation and apoptosis is associated with the activation of JNK and ERK in human embryo lung fibroblast cells. Toxicol Appl Pharmacol. 2007 ; 220: 18-24
97. Hao C, Hao W, Wei X, Xing L, Jiang J, Shang L. The role of MAPK in the biphasic dose-response phenomenon induced by cadmium and mercury in HEK293 cells. Toxicol Vitro. 2009 ; 23: 660-666
98. Cai W-J, Wang M-J, Moore PK, Jun H-M, Yao T, Zhu Y-C. The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation. Cardiovasc Res. 2007 ; 76: 29-40
99. Quirk JJ, Gannell JE, Fullerton MJ, Funder JW. Mechanisms of biphasic action of glucocorticoids on a-lactalbumin production by rat mammary gland explants. J Steroid Biochem. 1986 ; 24: 413-416
100. Quirk JJ, Funder JW. Steroid receptors and the generation of closely coupled/biphasic dose response curves. J Steroid Biochem. 1988 ; 30: 9-15
101. Boyd JG, Gordon T. A dose-dependent facilitation and inhibition of peripheral nerve regeneration by brain-derived neurotrophic factor. Eur J Neurosci. 2002 ; 15: 613-626
102. Hayashi T, Tasao LI, Su TP. Antiapoptotic and cytotoxic properties of delta opioid peptide [D-Ala2, D-Leu5]enkephalin in PC12 cells. Synapse. 2002 ; 43: 86-94
103. Chaube R, Joy KP. Estrogen regulation of in vitro brain tyrosine hydroxylase activity in the catfish Heteropneustes fossilis: interactions with cAMP-protein kinase A and protein kinase C systems in enzyme activation. Gen Comp Endocrinol. 2005 ; 141: 116-125
104. Koh SH, Jung B, Song CW, Kim Y. Kim YS and Kim SH. 15-Deoxy-delta12,14- prostaglandin J2, a neuroprotectant or a neurotoxicant?. Toxicology. 2005 ; 216: 232-243
105. Calabrese EJ. An assessment of anxiolytic drug screening tests: hormetic dose responses predominate. Crit Rev Toxicol. 2008 ; 38: 489-542
106. Calabrese EJ.. Modulation of the epileptic seizure threshold: Implications of biphasic dose responses. Crit Rev Toxicol. 2008 ; 38: 543-556
107. Welch H, Price CW, Randall WA. Increase in fatality rate of E-typhosa for white mice by streptomycin. J Am Pharmacol Assoc Sci Ed. 1946 ; 35: 155-158
108. Randall WA, Price CW, Welch H. Demonstration of hormesis (increase in fatality rate) by penicillin. Am J Publ Health. 1947 ; 37: 421-425
109. Stebbing ARD. Hormesis - stimulation of colony growth in campanularia-flexuosa (hydrozoa) by copper, cadmium and other toxicants. Aquat Toxicol. 1981 ; 1: 227-238
110. Stebbing ARD. Growth hormesis; a by-product of control. Health Phys. 1987 ; 52: 543-547
111. Luckey TD Radiation hormesis. FL: CRC Press ; 1991 :
112. Bloedau CV. 1884: 1362.
113. Schulz H. About the treatment of cholera with veratrine. Ger Med Weekly Paper. 1885 ; 11: 99
114. Calabrese EJ, Jonas WB. Homeopathy: clarifying its relationship to hormesis. Hum Exp Toxicol. 2010 ; 29: 531-536
115. Wiegant FAC, Van Rijn J, van Wijk R. Enhancement of the stress response by minute amounts of cadmium in sensitized Reuber H35 hepatoma cells. Toxicology. 1997 ; 116: 27-37
116. Wiegant FAC, Spieker N, van Wijk R. Stressor-specific enhancement of hsp induction by low doses of stressors in conditions of self- and cross-sensitization. Toxicology. 1998 ; 127: 107-119
117. Wiegant FAC, Souren JEM, van Wijk R. Stimulation of survival capacity in heat-shocked cells by subsequent exposure to minute amounts of chemical stressors: role of similarity in hsp-inducing effects. Hum Exp Toxicol. 1999 ; 18: 460-470
118. Van Wijk R, Wiegant FAC. The similar principle as a therapeutic strategy: a research program on stimulation of self defense in disordered mammalian cells. Alternative Ther Health Med. 1997 ; 3: 33-38
119. Van Wijk R, Ovelgönne JH, de Koning E, Jaarsveld K, van Rijn J, Wiegant FA. Mild step-down heating causes increased transcription levels of hsp68 and hsp84 mRNA and enhances thermotolerance development in Reuber H35 hepatoma cells. Int J Hyperther. 1994 ; 10: 115-125
120. Calabrese EJ, Jonas WB. Evaluating homeopathic drugs within a biomedical framework. Hum Exp Toxicol. 2010 ; 29: 545-549
121. Bellavite P, Chirumbolo S, Marzotto M. Hormesis and its relationship with homeopathy. Hum Exp Toxicol. 2010 ; 29 (7). 573-579
122. Bohme H Hugo Schulz (8/6/1853-7/13/1932). His life and work. Freien University of Berlin, Germany: Dissertation ; 1986 :
123. Bernard C. France: J.-B. Baillière et fils ; 1877 :
124. Aitken RS. On the renal threshold for chloride in man. J Physiol. 1930 ; 67: 199-210
125. Ambard L. Physiologie normale et pathologique des reins, et seq. 2 nd ed. Paris, 1920. Paris: ; 1920 :
126. Haden RL. The relation of the chloride metabolism to the toxemia of lobar pneumonia: preliminary report. J Lab Clin Med. 1925 ; 10: 0337-0342
127. Haldane JS, Priestley JG. The regulation of excretion of water by the kidneys. J Physiol. 1916 ; 50: 296-303
128. Magnus AH.. On dieresis. II announcement: comparison of the diuretic effectiveness of isotonic saline solutions. Arch Exp Pathol Pharmakol. 1900 ; 44: 396-433
129. Cushny AR The secretion of the urine. London: ; 1926 :
130. Clark AJ. The historical aspects of quackery, part 2. Br Med J. 1927 ; 2: 589-590
131. Clark AJ. The reaction between acetyl choline and muscle cells. J Physiol. 1926 ; 61: 530-546
132. Shackell LF, Ovelgönne JH, de Koning E, Jaarsveld K, van Rijn J, Wiegant FA. The relation of dosage to effect. J Pharmacol Exp Ther. 1924 ;: 23 53-24 65
133. Shackell LF.. Studies in protoplasm poisoning. I. Phenols. J Gen Physiol. 1923 ; 5: 783-805
134. Shackell LF.. The relation of dosage to effect. II. J Pharmacol Exp Ther. 1925 ; 15: 275-288
135. Mutscheller A. Physical standards of protection against roentgen x-ray dangers. Am J Roentgenol Radiat Ther. 1925 ; 13: 65-70
136. Mutscheller A. Safety standards of protection against x-ray danger. Radiol. 1928 ; 10: 468-476
137. Francis T. Quantitative relationships between the immunizing dose of epidemic influenza virus and the resultant immunity. J Exp Med. 1939 ; 69: 283-300
138. Calabrese EJ, Mattson MP, Calabrese V. Resveratrol commonly displays hormesis: occurrence and biomedical significance. Hum Exp Toxicol. 2010 ; 29: 980-1015
139. Calabrese EJ, Blain R. Hormesis and plant biology. Environ Pollut. 2009 ; 157: 42-48
140. Calabrese EJ. Hormesis is central to toxicology, pharmacology and risk assessment. Hum Exp Toxicol. 2010 ; 29: 249-261
141. Vichi P, Tritton TR. Stimulation of growth in human and murine cells by adriamycin. Canc Res. 1989 ; 49: 2679-2682
142. Demidova-Rice TN, Salomatina EV, Yaroslavsky AN, Herman IM, Hamblin MR. Low-level light stimulates excisional wound healing in mice. Laser Surg Med. 2007 ; 39: 706-715
143. Belz RG, Cedergreen N. Parthenin hormesis in plants depends on growth conditions. Environ Exp Bot. 2010 ; 69: 293-301
144. Wang JJ, Chervinsky PS, Rosen JM. Comparative biochemical studies of adriamycin and duanomycin in leukemia cells. Canc Res. 1972 ; 32: 511-515
145. Roper PR, Drewinko B. Comparison of in vitro methods to determine drug induced cell lethality. Canc Res. 1976 ; 36: 2182-2187
146. Huybrechts M, Symann M, Trout A. Effects of daunorubicin and doxorubicin, free and associated with DNA on hemopoietic stem cells. Canc Res. 1979 ; 39: 3738-3743
147. Calabrese EJ. Hormetic dose response relationships in immunology: occurrence, quantitative features of the dose response, mechanistic foundations, and clinical implications. Crit Rev Toxicol. 2005 ; 35: 89-295
148. Calabrese EJ Mild stress and healthy aging: applying hormesis in aging research and interventions. New York, NY: Springer ; 2008: 5-19.
149. Calabrese EJ, Baldwin LA. Scientific foundations of hormesis. Crit Rev Toxicol. 2001 ; 31: 349-695
150. Calabrese EJ, Baldwin LA.. Chemotherapeutics and hormesis. Crit Rev Toxicol. 2003 ; 33: 305-353
151. Results of the interphone international case-control study. J Epidemiol. 2010 ; 39: 675-694
152. Mattson MP, Calabrese EJ.. Best in small doses. New Sci. 2008 ; (August). 36-39
153. Hoffmann GR. A perspective on the scientific, philosophical and policy dimension of hormesis. Dose Response. 2009 ; 7: 1-51
154. Fosslien E. The hormetic morphogen theory of curvature and the morphogenesis and pathology of tubular and other curve structures. Dose Response. 2009 ; 7: 307-331
155. Falk IS.. The role of certain ions in bacterial physiology. A review (studies of salt action, VIII). Abstr Bacteriol. 1923 ; 7: 33 87 133-50 105 147
156. Marshall MS, Hrenoff AK. Bacteriostasis. J Infect Dis. 1937 ; 61: 42-54
157. Hotchkiss M The influence of various salts upon the growth of bacterium communis. University of Yale, New Haven, CT: PhD Thesis ; 1922 :
158. Hotchkiss M.. Studies on salt action. VI. The stimulating and inhibitive effect of certain cations upon bacterial growth. J Bacteriol. 1923 ; 8: 141-162
159. Matsuoka S, Dam E, Lecossier D, Clavel F, Hance AJ. Modulation of HIV-1 infectivity and cyclophilin A-dependence by gag sequence and target cell type. Retrovirology. 2009 ; 6: 21
160. Tao W, Richards C, Hamer D. Enhancement of HIV infection by cellulose sulfate. AIDS Res Hum Retrovir. 2008 ; 24: 925-929
161. Lee JB, Hayashi K, Hayashi T, Sankawa U, Maeda M.. Antiviral activities against HSV-1, HCMV, and HIV-1 of rhamnan sulfate from Monostroma latissimum. Planta Medica. 1999 ; 65: 439-441
162. Gao J, Wymore RS, Wang Y, et al. Isoform-specific stimulation of cardiac Na/K pumps by nanomolar concentrations of glycosides. J Gen Physiol. 2002 ; 119: 297-312
163. Abramowitz J, Dai C, Hirschi KK, et al. Ouabain and marinobufagenin- induced proliferation of human umbilical vein smooth muscle cells and a rat vascular smooth muscle cell line, A7r5. Circulation. 2003 ; 108: 3048-3053
164. Calabrese EJ. A dose of common sense. Good Clin Practice J. 2007 ;: 12-16
165. Calabrese EJ. Drug therapies for stroke and traumatic brain injury often display U-shaped dose responses: occurrence, mechanisms, and clinical implications. Crit Rev Toxicol. 2008 ; 38: 557-577
166. Calabrese EJ. Uncertainty factors and interindividual variation. Regul Toxicol Pharmacol. 1985 ; 5: 190-196
167. Calabrese EJ, Baldwin LA. The frequency of U-shaped dose responses in the toxicological literature. Toxicol Sci. 2001 ; 62: 330-338
168. Abete P, Cacciatore F, Testa G, et al. Clinical application of ischemic preconditioning in the elderly. Dose Response. 2010 ; 8: 34-40
169. Rattan SIS, Demirovic D. Hormesis can and does work in humans. Dose Response. 2010 ; 8: 58-63
170. Reynolds AR. Potential relevance of bell-shaped and U-shaped dose-responses for the therapeutic targeting of angiogenesis in cancer. Dose Response. 2010 ; 8: 253-284
171. Satti J. The emerging low-dose therapy for advanced cancers. Dose Response. 2009 ; 7: 208-220
172. Sonneborn JS. Mimetics of hormetic agents: stress-resistance triggers. Dose Response. 2010 ; 8: 97-121
173. Luckey TD. Radiation hormesis: the good, the bad, and the ugly. Dose Response. 2006 ; 4: 169-190
174. Calabrese EJ, Stanek EJ, Nascarella MA.. Evidence for hormesis in mutagenicity dose-response relationships. Mutat Res. 2011 ; 726 (2). 91-97
175. Sykes PJ, Day TK, Swinburne SJ, et al. In vivo mutagenic effect of very low dose radiation. Dose Response. 2006 ; 4 (4). 309-316
176. Sykes PJ, Morley AA, Hooker AM. The PKZ1 recombination mutation assay: a sensitive assay for low dose studies. Dose Response. 2006 ; 4: 91-105
177. Dianzani C. Substance P increases neutrophil adhesion to human umbilical vein endothelial cells. Br J Pharmacol. 2003 ; 139: 1103-1110
178. Day TK, Zeng G, Hooker AM. Extremely low doses of x-radiation can induce adaptive responses in mouse prostate. Dose Response. 2007 ; 5: 315-322
179. Hooker AM, Bhat M, Day TK, et al. The linear not-threshold models does not hold for low-dose ionizing radiation. Radiat Res. 2004 ; 162: 447-452
180. Stanek EJ, Calabrese EJ. Predicting low dose effects for chemicals in high throughput studies. Dose Response. 2010 ; 8: 301-316
181. Calabrese EJ. The future of hormesis: where do we go from here?. Crit Rev Toxicol. 2001 ; 31 ((4&5)). 637-648
182. Henschler D. The origin of hormesis: historical background and driving forces. Hum Exp Toxicol. 2006 ; 25: 347-351
183. Calabrese EJ, Baldwin LA. The marginalization of hormesis. Toxicol Pathol. 1999 ; 27: 187-194
184. Calabrese EJ, Baldwin LA. Chemical hormesis: its historical foundations as a biological hypothesis. Toxicol Pathol. 1999 ; 27: 195-216
185. Calabrese EJ, Baldwin LA. Scientific foundations of hormesis. Crit Rev Toxicol. 2001 ; 31: 349-695
186. Im HK, Im WB, Von Voigtlander PF, Carter DB, Murray BH, Jacobsen EJ. Characterization of U-101017 as a GABAA receptor ligand of dual functionality. Brain Res. 1996 ; 714: 165-168
187. Jacobsen EJ, Stelzer LS, TenBrink RE, et al. Piperazine imidazo[1,5-a]quinoxaline ureas as high-affinity GABAA ligands of dual functionality. J Med Chem. 1999 ; 42: 1123-1144
188. Jacobsen EJ, TenBrink RE, Stelzer LS, et al. High-affinity partial agonist imidazo[1,5-a]quinoxaline amides, carbamates, and ureas at the aminobutyric acid A/benzodiazepine receptor complex. J Med Chem. 1996 ; 39: 158-175
189. Jacobsen EJ, Stelzer LS. Belonga KL, et al. 3-Phenylsubstituted imidazo[1,5-a]quinoxalin-4-ones and imidazo[1,5-a]quinoxaline ureas that have high affinity at the GABAA/benzodiazepine receptor complex. J Med Chem. 1996 ; 39: 3820-3836
190. Calabrese EJ Multiple chemical interactions. MI: Lewis Publishers ; 1991 :
191. Belz RG, Cedergreen N, Sorensen H.. Hormesis in mixtures: Can it be predicted?. Sci Total Environ. 2008 ; 404: 77-87
192. Flood JF, Landry DW, Jarvik ME. Cholinergic receptor interactions and their effects on long-term memory processing. Brain Res. 1981 ; 215: 177-185
193. Flood JF, Smith GE, Cherkin A. Memory enhancement: supra-additive effect of subcutaneous cholinergic drug combinations in mice. Psychopharmacol. 1985 ; 86: 61-67
194. Flood JF, Smith GE, Cherkin A. Two-drug combinations of memory enhancers: effect of dose ratio upon potency and therapeutic window in mice. Life Sci. 1988 ; 42: 2145-2154
195. Butler DE, Nordin IC, L'Italien YJ, Zweisler L, Poschel PH, Marriott JG. Amnesia-reversal activity of a series of N[(disubstituted-amino)alkyl]-2-oxo-1- pyrrolidine acetamides, including pramiracetam. J Med Chem. 1984 ; 27: 684-691
196. Butler DE, Leonard JD, Caprathe BW, et al. Amnesia-reversal activity of a series of cyclic imides. J Med Chem. 1987 ; 30: 498-503
197. Calabrese EJ, Mattson MP. Hormesis provides a generalized quantitative estimate of biological plasticity. J Cell Comm Signal. 2011 ; 5: 25-38
198. Martius-Rostock F. The Arndt-Schulz Axiom. Munich Medical Weekly News. 1923 ; 70: 1-4
199. Calabrese EJ, Nascarella MA. Tumor resistance explained by hormesis. Dose Response. 2010 ; 8: 80-82
200. Nascarella MA, Stanek EJ, Hoffmann GR, Calabrese EJ. Quantification of hormesis in anti-cancer agent dose-responses. Dose Response. 2009 ; 7: 160-171
201. Calabrese EJ. P-Glycoprotein efflux transporter activity often displays biphasic dose response relationships. Crit Rev Toxicol. 2008 ; 38: 473-477
202. Murray CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a dealy of lethal cell injury in ischemic myocardium. Circulation. 1986 ; 74: 1124-1136
203. Dambraust T, Cornish HH. Effect of pretreatment of rats with carbon tetrachloride on tolerance development. Toxicol Appl Pharmacol. 1970 ; 17: 83
204. Glende EA. Carbon tetrachloride-induced protection against carbon-tetrachloride toxicity: role of liver microsomal drug-metabolizing system. Biochem Pharmacol. 1972 ; 21: 1697
205. Ugazio G, Koch RR, Recknage RO. Reversibility of liver damage in rats rendered resistant to carbon-tetrachloride by prior carbon-tetrachloride administration: bearing on lipoperoxidation hypothesis. Exp Mol Pathol. 1973 ; 18: 281-289
206. Samson L, Cairns J. A new pathway for DNA in Escherichia coli. Nature. 1977 ; 267: 281-283
207. Olivieri G, Bodycote J, Wolff S. Adaptive response of human-lymphocytes to low concentrations of radioactive thymidine. Science. 1984 ; 223: 594-597
208. Marber MS, Joy MD, Yellon DM. Is warm-up in angina ischaemic preconditioning?. Br Heart J. 1994 ; 72: 213-215
209. Evrengul H, Celek T, Tanriverdi H, Kaftan A, Dursunoglu D, Kilic M. The effect of preinfarction angina on clinical reperfusion time in patients with acute myocardial infarction receiving successful thrombolytic therapy. Can J Cardiol. 2005 ; 21: 915-920
210. Volkman DJ, Lane HC, Fauci AS. Antigen-induced in vitro antibody production in humans: a model for B cell activation and immunoregulation. Proc Natl Acad Sci. 1981 ; 78: 2528-2531
211. Damuth E, Heidelbaugh J, Malani PN, Cinti SK. An elderly patient with fluoroquinolone-associated Achilles tendinitis. Am J Geriatr Pharmacother. 2008 ; 6: 264-268
212. Liu HH. Safety profile of the fluoroquinolones focus on levofloxacin. Drug Saf. 2010 ; 33: 353-369
213. Pouzaud F, Bernard-Beaubois K, Thevenin M, Warnet JM, Hayem G, Rat P.. In vitro discrimination of fluoroquinolones toxicity on tendon cells: Involvement of oxidative stress. J Pharmacol Exp Ther. 2004 ; 308: 394-402
214. Lefer DF. A new gaseous signaling molecule emerges: cardioprotective role of hydrogen sulfide. Proc Natl Acad Sci. 2007 ; 104: 17907-17908
215. Cai WJ, Wang MJ, Moore PK, Jin HM, Yao T, Zhu YC. The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation. Cardiovas Res. 2007 ; 76: 29-40
216. Kubo S, Doe I, Kurokawa Y, Nishikawa H, Kawabata A. Direct inhibition of endothelial nitric oxide synthase by hydrogen sulfide: contribution to dual modulation of vascular tension. Toxicology. 2007 ; 232: 138-146
217. Whiteman M, Li L, Rose P, Tan CH, Parkinson DB, Moore PK. The effect of hydrogen sulfide donors on lipopolysaccharide-induced formation of inflammatory mediators in macrophages. Antioxid Redox Signal. 2010 ; 12: 1147-1154
218. Cai WJ, Wang MJ, Ju LH, Wang C, Zhu YC. Hydrogen sulfide induced human colon cancer cell proliferation: Role of Akt, ERk and p21. Cell Biol Int. 2010 ; 34: 565-572
219. Nunn AVW, Bell JD, Guy GW. Lifestyle-induced metabolic inflexibility and accelerated ageing syndrome: insulin resistance, friend or foe?. Nutr Metab. 2009 ; 6: 16
220. Nunn AVW, Guy GW, Bell JD. Endocannabinoids, FOXO and the metabolic syndrome: redox, function and tipping point: the view from two systems. Immunobiol. 2010 ; 215: 617-628
221. Desjardins AU. Radiotherapy for inflammatory conditions. J Am Med Assoc. 1931 ; 96: 401-408
222. Desjardins AU. Radiotherapy for inflammatory conditions. New Engl J Med. 1939 ; 221: 801-809
223. Lucinian JH. Treatment of otitis media and mastoiditis by the roentgen ray. Am J Roentgenol Radiat Ther. 1936 ; 36: 946-953
224. Garland LH. The roentgen treatment of certain types of arthritis. Radiology. 1935 ; 25: 416
225. Prudden JF, Allen J. The clinical acceleration of healing with a cartilage preparation. J Am Med Assoc. 1965 ; 192: 352-356
226. Werner H. Further observations of the clinical value of a growth-promoting substance in wound treatment. Br J Surg. 1945 ; 32: 518-522
227. Kerr AB, Werner H. The clinical value of a growth-promoting substance in the treatment of indolent wounds. Br J Surg. 1944 ; 32: 281-287
228. Nguyen DT, Orgill DP, Murphy FG. Biomaterials for treating skin loss. Woodhead Publishing (UK/Europe) and CRC Press (US): Cambridge/Boca Raton ; 2009: 25-57.
229. Parker RC, Morgan JF, Morton HJ. Nutrition of animal cells in tissue culture. III. Effect of ethyl alcohol on cell survival and multiplication. J Cell Comp Physiol. 1950 ; 36: 411-420
230. Healy GM, Teleki S, von Seefried A, Walton MJ, Macmorine HG. Improved chemically defined basal medium (CMRL-1969) for primary monkey kidney and human diploid cells. Appl Microbiol. 1971 ; 21: 1-5
231. Iavicoli I, Carelli G, Stanek EJ, Castellino N, Calabrese EJ. Effects of low doses of dietary lead on puberty onset in female mice. Reprod Toxicol. 2004 ; 19: 35-41
232. Iavicoli I, Carelli G, Stanek EJ, Castellino N, Li Z, Calabrese EJ. Low doses of dietary lead are associated with a profound reduction in the time to the onset of puberty in female mice. Reprod Toxicol. 2006 ; 22: 586-590
233. Jones A, Stanek EJ, Anderton D, Calabrese EJ Knowledge and attitudes concerning hormesis by toxicologists and risk assessors. Amherst, MA: University of Massachusetts ; 2010 :
234. Calabrese EJ.. Hormesis: principles and applications for pharmacology and toxicology. Am J Pharmacol Toxicol. 2008 ; 3: 59-71
235. Calabrese EJ. Paradigm lost, paradigm found: the reemergence of hormesis as a fundamental dose response model in the toxicological sciences. Environ Pollut. 2005 ; 138: 378-411